Global Anatomic Pathology Market Outlook, 2029

The global anatomic pathology market is expected growth, this growth is driven by several factors, including the increasing incidence of cancer and other chronic diseases, the growing adoption of advanced pathology equipment, and the increasing focus on personalized medicine. One of the major factors driving the growth of the anatomic pathology market is the increasing incidence of cancer and other chronic diseases. The rapid growth in the geriatric population and the rising incidence of cancer and other chronic diseases are fueling the demand for anatomic pathology services. As the population ages, there is a higher risk of developing chronic diseases such as cancer, which require accurate diagnosis through anatomic pathology procedures. The increasing adoption of advanced pathology equipment is another key factor driving the growth of the anatomic pathology market. The report highlights the rising adoption of digital pathology, whole slide imaging, and telepathology, which are revolutionizing the field of anatomic pathology. These technologies allow for more efficient and accurate diagnoses, as well as improved collaboration between pathologists. For instance, the COVID-19 pandemic significantly boosted the adoption of digital pathology as it enabled pathologists to work remotely and address the backlog of cases. According to the research report, “Global Anatomic Pathology Market Outlook, 2029” published by Bonafide Research, the market is anticipated to grow with 7% CAGR by 2024-29.The growing focus on personalized medicine is also propelling the growth of the anatomic pathology market. Personalized medicine relies on the analysis of a patient's individual genetic makeup to guide treatment decisions. Anatomic pathology plays a vital role in personalized medicine by providing information about the molecular characteristics of a patient's disease, which can be used to select the most effective treatment options. However, the report also identifies some challenges that are hindering the growth of the anatomic pathology market. These challenges include the availability of refurbished anatomic pathology systems, the lack of skilled professionals, and product recalls. The presence of refurbished systems at lower prices can be attractive to medium and small-sized laboratories in developing countries, potentially limiting sales of new equipment. The anatomic pathology market is expected to experience significant growth in the coming years. The increasing burden of chronic diseases, the adoption of advanced technologies, and the growing focus on personalized medicine are all contributing to this growth. However, market players need to address the challenges associated with skilled workforce shortages and ensure the quality and reliability of anatomic pathology equipment.

Market Drivers • Rising Burden of Chronic Diseases: The growing prevalence of cancer and other chronic diseases, particularly among the aging population, is a major driver of the anatomic pathology market. As the risk of chronic diseases increases with age, the demand for accurate diagnoses through anatomic pathology procedures surges. This translates to a heightened need for anatomic pathology services and equipment. • Technological Advancements: The adoption of advanced technologies like digital pathology, whole slide imaging (WSI), and telepathology is revolutionizing anatomic pathology practices. These technologies offer significant advantages, including: • Personalized Medicine Focus: The growing emphasis on personalized medicine is a significant driver for the anatomic pathology market. Personalized medicine tailors treatment plans based on a patient's individual genetic makeup. Anatomic pathology plays a crucial role in this approach by providing insights into the molecular characteristics of diseases, enabling the selection of the most effective treatment options for each patient. Market Challenges

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

• Availability of Refurbished Equipment: The presence of refurbished anatomic pathology systems at lower prices can be attractive to budget-conscious laboratories, particularly in developing countries. This can limit sales of new, technologically advanced equipment from established market players. • Skilled Workforce Shortages: The field of anatomic pathology faces a shortage of skilled professionals, including pathologists and technicians. This can lead to delays in diagnoses and hinder the overall efficiency of anatomic pathology services. • Product Recalls and Quality Concerns: Product recalls due to malfunctions or safety issues with anatomic pathology equipment can negatively impact market growth. Maintaining the quality and reliability of equipment is crucial for ensuring patient safety and fostering trust in the market. ? Market Trends • Growing Adoption of AI-powered Pathology Solutions: Artificial intelligence (AI) is rapidly transforming the anatomic pathology landscape. AI-powered solutions are being integrated into various aspects of anatomic pathology workflows, including image analysis, diagnosis support, and biomarker identification. These solutions hold immense potential for further improving diagnostic accuracy, efficiency, and workflow optimization. • Strategic Partnerships and Mergers & Acquisitions: To stay competitive and leverage advancements, key players in the anatomic pathology market are increasingly engaging in strategic partnerships and mergers & acquisitions. These collaborations can lead to the development of innovative technologies, expansion into new markets, and access to broader customer bases. • Emphasis on Reimbursement Policies: Reimbursement policies play a critical role in the adoption of new technologies and services within the anatomic pathology market. Governments and healthcare institutions are increasingly focusing on developing favorable reimbursement policies to encourage the implementation of advanced technologies like digital pathology, ultimately improving patient care and outcomes. Based on the report, the application segment is distinguished into Disease Diagnosis, Drug Discovery and Others. The disease diagnosis segment is leading in the anatomic pathology market due to the increasing prevalence of chronic diseases, particularly cancer, which necessitates accurate and timely pathological diagnosis for effective treatment planning and improved patient outcomes.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

The prominence of the disease diagnosis segment in the anatomic pathology market is primarily driven by the escalating incidence of chronic diseases, especially various types of cancer, which require precise and early diagnosis to enable appropriate treatment interventions. Anatomic pathology, with its focus on the examination of tissue samples to identify disease conditions, plays a crucial role in the medical diagnostic process. As the global burden of chronic diseases rises, so does the need for sophisticated and accurate diagnostic methods, positioning the disease diagnosis segment at the forefront of the market. Cancer, in particular, is a leading cause of morbidity and mortality worldwide, with millions of new cases diagnosed each year. The critical need for early and accurate cancer diagnosis cannot be overstated, as early detection significantly increases the chances of successful treatment and survival. Anatomic pathology provides detailed insights into the cellular and tissue-level changes associated with cancer, enabling pathologists to accurately diagnose the type and stage of cancer. This detailed pathological information is essential for developing targeted and effective treatment plans tailored to the specific characteristics of the patient's disease. Technological advancements in anatomic pathology have further bolstered the disease diagnosis segment. Innovations such as digital pathology, advanced imaging techniques, and molecular pathology have revolutionized the diagnostic process. Digital pathology, for instance, allows for high-resolution scanning and analysis of tissue slides, facilitating better visualization and interpretation of pathological findings. Molecular pathology techniques enable the identification of specific genetic and molecular markers associated with diseases, providing deeper insights into the pathogenesis and potential treatment targets. The integration of artificial intelligence (AI) and machine learning in pathology is enhancing diagnostic accuracy and efficiency. AI algorithms can assist pathologists in identifying patterns and anomalies in tissue samples, reducing diagnostic errors and speeding up the diagnostic process. These technological enhancements ensure that pathological diagnoses are not only accurate but also delivered in a timely manner, which is critical for the effective management of chronic diseases. North America is leading in the anatomic pathology market due to its advanced healthcare infrastructure, high adoption of innovative technologies, and significant investment in research and development, while the Asia-Pacific (APAC) region is experiencing rapid growth driven by increasing healthcare expenditures, a rising prevalence of chronic diseases, and expanding access to advanced diagnostic services. North America's leadership in the anatomic pathology market is primarily attributable to its well-established healthcare infrastructure, which is characterized by the presence of numerous state-of-the-art medical facilities and a highly skilled workforce. The region boasts a high level of adoption of cutting-edge technologies, such as digital pathology, molecular diagnostics, and artificial intelligence, which enhance the accuracy, efficiency, and capabilities of anatomic pathology services. Additionally, North America has a strong focus on research and development, supported by substantial investments from both the public and private sectors. This commitment to innovation drives the continuous development of new diagnostic tools and techniques, maintaining the region's competitive edge in the market. The robust regulatory framework in North America also plays a crucial role in ensuring high standards of quality and safety in diagnostic practices. Agencies like the Food and Drug Administration (FDA) oversee the approval and regulation of diagnostic tools and procedures, ensuring that they meet rigorous standards. This regulatory environment fosters trust and reliability in the diagnostic services provided, further cementing North America's leadership in the anatomic pathology market. On the other side, Asia-Pacific (APAC) region is witnessing significant growth in the anatomic pathology market, propelled by several key factors. One of the primary drivers is the increasing healthcare expenditure across many APAC countries, reflecting a growing commitment to improving healthcare infrastructure and expanding access to medical services. As economies in the region continue to develop, there is a parallel increase in the funding allocated to healthcare, including investments in advanced diagnostic technologies and services. The rising prevalence of chronic diseases, such as cancer and cardiovascular conditions, in the APAC region is another critical factor contributing to the market's growth. With an aging population and changing lifestyles, the incidence of these diseases is increasing, creating a heightened demand for accurate and timely diagnostic services. Anatomic pathology, with its focus on detailed tissue analysis, plays a crucial role in diagnosing and managing these conditions. Expanding access to advanced diagnostic services in the APAC region is facilitated by improvements in healthcare infrastructure and increased availability of trained medical professionals. Many countries in the region are actively enhancing their healthcare systems to provide better diagnostic and treatment options to their populations. This expansion is supported by government initiatives and collaborations with international healthcare organizations, which help in adopting global best practices and technologies. • In May 2023, PathAI, an AI-powered pathology company based in the United States, launched its ""AISight"" product. AISight helps evaluate the percentage of PD-L1 positive tumors and immune cells in lung cancer . This signifies the growing adoption of AI in anatomic pathology for improved analysis and potential for personalized cancer treatment plans. • Sheikh Shakhbout Medical City (SSMC) in the United Arab Emirates announced the launch of a state-of-the-art Anatomical Pathology Laboratory in June 2023. This lab utilizes AI applications and tools, highlighting the increasing acceptance of digital pathology solutions in the Middle East to enhance diagnostic efficiency. • In April 2021, Abbott Laboratories (US) partnered with Walgreens Boots Alliance (US) to offer affordable healthcare services, including diagnostic tests. Such collaborations can improve access to diagnostic tools and potentially lead to earlier disease detection. • China's anatomic pathology market is experiencing a boom, with events like the 2nd Digital Pathology & AI Congress planned for September 2022. This signifies the growing focus of companies and organizations on expanding the adoption of advanced pathology solutions in developing economies. • In September 2021, F. Hoffmann-La Roche Ltd. (Switzerland) announced a merger with GenMark Diagnostics (US) to expand its molecular diagnostic portfolio. This merger exemplifies how established players are strategically acquiring capabilities to address a wider range of pathology needs. Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029 Aspects covered in this report • Anatomic Pathology market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Products and services • Instruments • Consumables • Services By Application • Disease Diagnosis • Drug Discovery • Others By End Users • Diagnostic centers • Hospitals • Research Centers The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Anatomic Pathology industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.